Peter Vallance Marshall

Title: Peter Vallance Marshall: Innovator in Pharmaceutical Chemistry

Introduction

Peter Vallance Marshall is a notable inventor based in Sandwich, GB. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 3 patents. His work focuses on innovative compounds that have the potential to impact medical treatments.

Latest Patents

Marshall's latest patents include the development of anhydrous crystalline forms of N-[1-(2-ethoxyethyl)-5-(N-ethyl-N-methylamino)-7-(4-methylpyridin-2-yl-amino)-1H-pyrazolo[4,3-d]pyrimidine-3-carbonyl]methanesulfonamide. This invention encompasses several key components: (1) anhydrous crystalline forms of the compound, (2) pharmaceutical compositions that include at least one such form, (3) methods for treating phosphodiesterase-5-mediated conditions using at least one such form, and (4) methods for preparing these forms. The compound has a specific structure that is crucial for its efficacy in medical applications.

Career Highlights

Peter Vallance Marshall is currently associated with Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer has allowed him to contribute to the development of innovative treatments that address various health conditions. His expertise in pharmaceutical chemistry has positioned him as a valuable asset in the industry.

Collaborations

Throughout his career, Marshall has collaborated with notable colleagues, including David Andrew Entwistle and Stefan Colin John Taylor. These collaborations have fostered an environment of innovation and have led to the advancement of several important projects in the pharmaceutical field.

Conclusion

Peter Vallance Marshall is a distinguished inventor whose work in pharmaceutical chemistry continues to influence the industry. His patents and collaborations reflect his commitment to advancing medical science and improving patient outcomes.